Loading clinical trials...
Loading clinical trials...
Engagement and Satisfaction With a ChatGPT-Supported Text Messaging Program for Smoking Cessation
The current research proposal aims to explore how a purpose driven LLM ChatGPT chatbot, BeFreeBot, might enhance an evidence-based text messaging smoking cessation program, BeFree. The research will consist of a formative evaluation comparing quitting related outcomes among users of BeFree+Bot and BeFree.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
Prolific
Washington D.C., District of Columbia, United States
Start Date
October 1, 2025
Primary Completion Date
December 30, 2025
Completion Date
January 30, 2026
Last Updated
October 3, 2025
150
ESTIMATED participants
BeFree+Bot
BEHAVIORAL
BeFree
BEHAVIORAL
Lead Sponsor
George Washington University
NCT07441928
NCT05733767
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions